We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 36.73% | 16.75 | 16.50 | 17.00 | 17.35 | 14.50 | 14.75 | 8,869,778 | 13:43:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -1.92 | 41.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/4/2024 13:52 | Shareholders havin the last toast here LOLsss | kryptonsnake | |
24/4/2024 13:48 | Thank you. I do recall some discussion about the shelf life of blood samples in terms of transport and test times etc, but believe it was not problematic. Obviously a ‘cradle to grave’ ( blood test to results) would be commercially profitable. | millwallfan | |
24/4/2024 13:48 | Up 37%. Did bones699 disappear up her own a*sehole LoLsss | kryptonsnake | |
24/4/2024 13:35 | Millwall yes in the UK pharma services. The US one was closed to save money for now an until sales increase enough to justify it. The UK facility has the capacity to expand and cope with demand for some time. It was discussed at the time and shipping etc is low cost for samples from other countries to the UK On a side note Cellkeep could be utilised in a number of other areas not just cancer although that is a huge market with so many companies operating in that liquid biopsy market. | bones698 | |
24/4/2024 13:22 | Apologies for my ignorance- but do we still operate the laboratories which process the samples and thus generate more income ? | millwallfan | |
24/4/2024 13:20 | This does look a good opportunity. Taken a nibble. | donald pond | |
24/4/2024 13:06 | It was obvious from the off it's going to head to 20p hence buying the dip :) | g2theary | |
24/4/2024 12:59 | Looks like the share price is ready to move on up soon. Could be a strong afternoon | spa362 | |
24/4/2024 12:41 | More fda clearances. Cellkeep sales, PDL1 and hers 2 kit sales, pharma services business increasing etc etc. The interesting part is recurring and increasing revenue for many years to come. The market is missing that along with investors. | bones698 | |
24/4/2024 12:14 | up 30 percent now mms ready to lift up | citys2874 | |
24/4/2024 12:11 | Just getting warmed up.This has form to multi bag | atmysignal | |
24/4/2024 12:07 | Should be in for a rally this afternoon great link and interview | citys2874 | |
24/4/2024 12:05 | Next rally incoming ;) | g2theary | |
24/4/2024 12:04 | And again Newland absolutely aced that, rally managed to get his points across effectively IMO. | gspanner | |
24/4/2024 12:02 | bones 698....don't forget the results... | htrocka2 | |
24/4/2024 11:44 | They eceived the usa patent for Cellkeep this morning by the way and there is a proactive interview on today's news and why it's big news. Great interview extremely positive. What's to come Thermo Fisher Bioview Prostate and ovarian in storage ready to develop Illumia Cellkeep sales Cellkeep patents received for USA and Europe Follow on contracts And we are fda cleared Not a bad list of things and that's without things we don't know are in talk about. Glad I'm. Not out of this. Only company in the world able to do what we offer | bones698 | |
24/4/2024 11:37 | volume crossed 6 million now, news and press coverage started, people finding out todays news and breakout crossing 200 day average has triggered a strong buying trend and breakout upwards | citys2874 | |
24/4/2024 11:34 | 20.00+ coming this afternoon | citys2874 | |
24/4/2024 11:19 | Fully Funded till Q2 2025 FROM 21mins | abs19 | |
24/4/2024 11:07 | beatme1 get a life you loser, what brokers do you know? | citys2874 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions